Diabetes and Epigenetics

Epigenetics, the study of changes in gene expression without altering the underlying DNA sequence, is increasingly recognized as a key factor in the development and progression of diabetes. Environmental factors such as diet, stress, and exposure to toxins can influence gene expression through epigenetic mechanisms, potentially increasing the risk of insulin resistance and Type 2 Diabetes. For example, modifications like DNA methylation and histone modification can affect genes involved in glucose metabolism and insulin sensitivity. Research is exploring how epigenetic changes can be reversed or modified to prevent or treat diabetes. This growing field offers potential for personalized treatments based on an individual's epigenetic profile, paving the way for more targeted and effective interventions.

    Related Conference of Diabetes and Epigenetics

    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Paris, France
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    October 27-28, 2025

    5th World Congress on Endocrine and Diabetes

    Madrid, Spain
    October 30-31, 2025

    5th Annual Summit on Diabetes and Endocrinology

    Paris, France
    November 03-04, 2025

    34th European Diabetes Congress

    Rome, Italy
    November 06-07, 2025

    8th Annual Meeting on Diabetes and Endocrinology

    Dubai, UAE
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Paris, France
    November 24-25, 2025

    6th International conference on Diabetic complications

    Barcelona, Spain
    February 23-24, 2026

    19th International Summit on Diabetes

    London, UK
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France

    Diabetes and Epigenetics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in